These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29687178)

  • 1. Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews.
    Hackett J; Thorneloe R; Side L; Wolf M; Horne R; Cuzick J; Smith SG
    Breast Cancer Res Treat; 2018 Aug; 170(3):633-640. PubMed ID: 29687178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beliefs About Medication and Uptake of Preventive Therapy in Women at Increased Risk of Breast Cancer: Results From a Multicenter Prospective Study.
    Thorneloe RJ; Horne R; Side L; Wolf MS; Smith SG;
    Clin Breast Cancer; 2019 Feb; 19(1):e116-e126. PubMed ID: 30518498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer worry in higher-risk women offered preventive therapy: a UK multicentre prospective study.
    Lloyd KE; Hall LH; Ziegler L; Smith SG;
    Breast Cancer Res Treat; 2021 Aug; 188(3):703-712. PubMed ID: 33733302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention.
    Korfage IJ; Fuhrel-Forbis A; Ubel PA; Zikmund-Fisher BJ; Greene SM; McClure JB; Smith DM; Alford SH; Fagerlin A
    Breast Cancer Res; 2013; 15(5):R74. PubMed ID: 24004815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability and adherence in a chemoprevention trial among women at increased risk for breast cancer attending the Modena Familial Breast and Ovarian Cancer Center (Italy).
    Razzaboni E; Toss A; Cortesi L; Marchi I; Sebastiani F; De Matteis E; Federico M
    Breast J; 2013; 19(1):10-21. PubMed ID: 23252601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's views on chemoprevention of breast cancer: qualitative study.
    Heisey R; Pimlott N; Clemons M; Cummings S; Drummond N
    Can Fam Physician; 2006 May; 52(5):624-5. PubMed ID: 17327893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge of Potential Harms and Benefits of Tamoxifen among Women Considering Breast Cancer Preventive Therapy.
    Thorneloe RJ; Hall LH; Walter FM; Side L; Lloyd KE; Smith SG;
    Cancer Prev Res (Phila); 2020 Apr; 13(4):411-422. PubMed ID: 31988145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. My Lived Experiences Are More Important Than Your Probabilities: The Role of Individualized Risk Estimates for Decision Making about Participation in the Study of Tamoxifen and Raloxifene (STAR).
    Holmberg C; Waters EA; Whitehouse K; Daly M; McCaskill-Stevens W
    Med Decis Making; 2015 Nov; 35(8):1010-22. PubMed ID: 26183166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis.
    Smith SG; Sestak I; Forster A; Partridge A; Side L; Wolf MS; Horne R; Wardle J; Cuzick J
    Ann Oncol; 2016 Apr; 27(4):575-90. PubMed ID: 26646754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
    Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
    Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finding the five-year window: A qualitative study examining young women's decision-making and experience of using tamoxifen to reduce BRCA1/2 breast cancer risk.
    Forrest LE; Forbes Shepherd R; Young MA; Keogh LA; James PA
    Psychooncology; 2021 Feb; 30(2):159-166. PubMed ID: 33006205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs' attitudes.
    Smith SG; Foy R; McGowan JA; Kobayashi LC; de Censi A; DeCensi A; Brown K; Side L; Cuzick J
    Br J Gen Pract; 2017 Jun; 67(659):e414-e427. PubMed ID: 28193617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid.
    Fagerlin A; Zikmund-Fisher BJ; Nair V; Derry HA; McClure JB; Greene S; Stark A; Hensley Alford S; Lantz P; Hayes DF; Wiese C; Claud Zweig S; Pitsch R; Jankovic A; Ubel PA
    Breast Cancer Res Treat; 2010 Feb; 119(3):613-20. PubMed ID: 19908143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Family Obligation Stress on Ugandan Women's Participation in Preventive Breast Health.
    Scheel JR; Parker S; Hippe DS; Patrick DL; Nakigudde G; Anderson BO; Gralow JR; Thompson B; Molina Y
    Oncologist; 2019 May; 24(5):624-631. PubMed ID: 30072390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Chemoprevention: Use and Views of Australian Women and Their Clinicians.
    Macdonald C; Saunders CM; Keogh LA; Hunter M; Mazza D; McLachlan SA; Jones SC; Nesci S; Friedlander ML; Hopper JL; Emery JD; Hickey M; Milne RL; Phillips KA;
    Cancer Prev Res (Phila); 2021 Jan; 14(1):131-144. PubMed ID: 33115784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic.
    Donnelly LS; Evans DG; Wiseman J; Fox J; Greenhalgh R; Affen J; Juraskova I; Stavrinos P; Dawe S; Cuzick J; Howell A
    Br J Cancer; 2014 Apr; 110(7):1681-7. PubMed ID: 24594998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Decision Making about Breast Cancer Prevention in Action: The Intersection of Perceived Risk, Perceived Control, and Social Context: NRG Oncology/NSABP DMP-1.
    Gunn CM; Bokhour BG; Parker VA; Battaglia TA; Parker PA; Fagerlin A; McCaskill-Stevens W; Bandos H; Blakeslee SB; Holmberg C
    Med Decis Making; 2019 Apr; 39(3):217-227. PubMed ID: 30803311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer anxiety's associations with responses to a chemoprevention decision aid.
    Dillard AJ; Scherer L; Ubel PA; Smith DM; Zikmund-Fisher BJ; McClure JB; Greene S; Stark A; Fagerlin A
    Soc Sci Med; 2013 Jan; 77():13-9. PubMed ID: 23200299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation.
    Metcalfe KA; Snyder C; Seidel J; Hanna D; Lynch HT; Narod S
    Fam Cancer; 2005; 4(2):97-103. PubMed ID: 15951959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.
    Ropka ME; Keim J; Philbrick JT
    J Clin Oncol; 2010 Jun; 28(18):3090-5. PubMed ID: 20458026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.